Strumento inattivo

Altre lingue Tetraphase Pharmaceuticals, Inc.

Azioni

US88165N2045

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Tetraphase Pharmaceuticals, Inc. Enters into A Termination of Lease and Voluntary Surrender of Premises Agreement	18/12/20
Tetraphase Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2020	13/10/20
La Jolla Pharmaceutical Completes Merger with Tetraphase Pharmaceuticals	31/07/20
Tetraphase Pharmaceuticals, Inc. Announces Executive Changes	29/07/20
Tetraphase Pharmaceuticals, Inc. Announces Resignation of Larry Edwards as CEO	29/07/20
Tetraphase Pharmaceuticals, Inc. Announces Appointment of Michael Hearne as Chief Financial Officer	29/07/20
Tetraphase Pharmaceuticals, Inc.(NasdaqGS:TTPH) dropped from S&P TMI Index	29/07/20
La Jolla Pharmaceutical Company completed the acquisition of Tetraphase Pharmaceuticals, Inc..	28/07/20
Armistice Capital Enters into Support Agreement with La Jolla Pharmaceutical	30/06/20
Tetraphase Pharmaceuticals, Inc.(NasdaqGS:TTPH) dropped from Russell Microcap Value Index	26/06/20
Tetraphase Pharmaceuticals, Inc.(NasdaqGS:TTPH) dropped from Russell Microcap Index	26/06/20
La Jolla Pharmaceutical Company : to Acquire Tetraphase Pharmaceuticals, Inc	25/06/20
TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	24/06/20
Tetraphase Pharmaceuticals : La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.	24/06/20
Melinta Therapeutics, Inc. cancelled the acquisition of Tetraphase Pharmaceuticals, Inc..	24/06/20
La Jolla Pharmaceutical Sends Letter to Tetraphase Pharmaceuticals	22/06/20
TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	22/06/20
Tetraphase Pharmaceuticals : Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta	22/06/20
TETRAPHASE PHARMACEUTICALS INC : Other Events (form 8-K)	05/06/20
United States Food and Drug Administration Approves XERAVA of Tetraphase Pharmaceuticals, Inc	05/06/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tetraphase Pharmaceuticals, Inc.

Azioni

US88165N2045

Altre lingue

Filtri